The Veteran's seborrheic dermatitis has affected less than five percent of her entire body and greater than five percent, but less than twenty percent, of exposed areas. The Board finds that the use of topical corticosteroids did not constitute systemic therapy as defined by VA regulations.
The deciding factor: The Veteran's seborrheic dermatitis affects less than 20% of her entire body and does not meet the criteria for a higher rating under Diagnostic Code 7806, which requires at least 20% of exposed areas or systemic therapy such as corticosteroids.
- Claimed conditions
- Seborrheic Dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- August 16, 2017
- Citation
- 1733506
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1733506.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's skin allergies were found not to meet the criteria for a compensable rating, as his symptoms did not result in at least five percent of his entire body or exposed areas being affected.
- Granted
The Veteran's claim for SMC is granted, effective February 1, 2021. The decision is based on the combination of his service-connected PTSD and other disabilities that independently rate at least 60 percent.
- Remanded (sent back)
The Veteran's claims for increased ratings and service connection are being remanded due to the need for additional examinations and an opinion regarding the relationship between current vision loss and in-service radiofrequency radiation exposure.
- Granted
The Veteran's seborrheic dermatitis on the scalp was reduced from a 30 percent rating to zero percent effective December 1, 2020. The Board has restored the 30 percent rating for the Veteran's seborrheic dermatitis as it found that there is at least equipoise evidence of improvement in her ability to function under ordinary conditions of life and work.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.